{"title":"[COCHRANE SYSTEMATIC REVIEWS ON PROSTATE CANCER].","authors":"D Vrdoljak","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate cancer is a common malignant tumor of the elderly, which accounts for a significant proportion of total morbidity\nbut very low of mortality. In Croatia, it is the second most common cancer in men. Currently, there are many doubts\nconcerning screening, early detection and treatment of prostate cancer. Therefore, this article brings results of Cochrane\nsystematic reviews (SRs) on the topic of prostate cancer published in the last eight years. In June 2016, Cochrane database\nof systematic reviews was searched using the following keywords: Systematic Reviews, and Prostate Cancer (Malignancy,\nNeoplasm). Inclusion criterion was publication date of the Cochrane SR or its update in the last eight years. The abstracts\nwere initially screened and those that matched the topic were included in further analysis. Then full texts of all SRs involved\nwere obtained. SRs were classified into four topics: prevention, screening, treatment and psychosocial aspects. Our search\nretrieved a total of 19 Cochrane SRs on the topic of prostate cancer. Excluded were four articles that did not match the\nspecific topic, and the remaining 15 full texts were obtained. One of these was on screening, two on prevention, the\nmajority, i.e. eleven were on treatment, and one on the psychosocial aspects related to prostate cancer. Based on the\nresults of the Cochrane SRs on prostate cancer, instead of mass/population screening, the individualized/opportunistic\nscreening approach should be applied in men aged 55-69, always providing full information to the patient and taking into\naccount the potential benefits and harms of this procedure.</p>","PeriodicalId":35756,"journal":{"name":"Acta Medica Croatica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Medica Croatica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Prostate cancer is a common malignant tumor of the elderly, which accounts for a significant proportion of total morbidity
but very low of mortality. In Croatia, it is the second most common cancer in men. Currently, there are many doubts
concerning screening, early detection and treatment of prostate cancer. Therefore, this article brings results of Cochrane
systematic reviews (SRs) on the topic of prostate cancer published in the last eight years. In June 2016, Cochrane database
of systematic reviews was searched using the following keywords: Systematic Reviews, and Prostate Cancer (Malignancy,
Neoplasm). Inclusion criterion was publication date of the Cochrane SR or its update in the last eight years. The abstracts
were initially screened and those that matched the topic were included in further analysis. Then full texts of all SRs involved
were obtained. SRs were classified into four topics: prevention, screening, treatment and psychosocial aspects. Our search
retrieved a total of 19 Cochrane SRs on the topic of prostate cancer. Excluded were four articles that did not match the
specific topic, and the remaining 15 full texts were obtained. One of these was on screening, two on prevention, the
majority, i.e. eleven were on treatment, and one on the psychosocial aspects related to prostate cancer. Based on the
results of the Cochrane SRs on prostate cancer, instead of mass/population screening, the individualized/opportunistic
screening approach should be applied in men aged 55-69, always providing full information to the patient and taking into
account the potential benefits and harms of this procedure.
期刊介绍:
ACTA MEDICA CROATICA publishes original contributions to medical sciences, that have not been previously published. All manuscripts should be written in English.